CSL Ltd logo

CSL Ltd

CSLLY · OTC · Pharmaceuticals, Biotech · Founded 1961

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants.

Current Price
—
Market Cap
—
Return Since Last Split
+37%
Last Split
Mar 2, 2026
Total Splits
1
Cumulative Multiple
2×

What If You Bought CSLLY Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
200 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Mar 2, 2026$26.062-for-12×2×

CSL Ltd Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

CSL Ltd's latest record in the split calendar is a 2-for-1 forward split effective 2026-03-02.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.